Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1978 2
1982 3
1983 3
1984 3
1985 1
1986 1
1987 2
1988 5
1989 8
1990 7
1991 5
1992 4
1993 8
1994 6
1995 6
1996 4
1997 6
1998 8
1999 7
2000 4
2001 4
2002 3
2003 7
2004 5
2005 6
2006 7
2007 7
2008 7
2009 9
2010 12
2011 10
2012 9
2013 10
2014 8
2015 8
2016 15
2017 12
2018 14
2019 13
2020 18
2021 9
2022 15
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Childhood malignant kidney neoplasm"
Page 1
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma.
Alchahin AM, Mei S, Tsea I, Hirz T, Kfoury Y, Dahl D, Wu CL, Subtelny AO, Wu S, Scadden DT, Shin JH, Saylor PJ, Sykes DB, Kharchenko PV, Baryawno N. Alchahin AM, et al. Nat Commun. 2022 Sep 30;13(1):5747. doi: 10.1038/s41467-022-33375-w. Nat Commun. 2022. PMID: 36180422 Free PMC article.
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer in adults. When ccRCC is localized to the kidney, surgical resection or ablation of the tumor is often curative. ...Here we use fresh patient samples that include treatment-naive primar …
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer in adults. When ccRCC is localized to the kidney …
Everolimus.
Houghton PJ. Houghton PJ. Clin Cancer Res. 2010 Mar 1;16(5):1368-72. doi: 10.1158/1078-0432.CCR-09-1314. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179227 Free PMC article. Review.
Everolimus significantly increased progression-free survival (median PFS for the everolimus treated group was 4.0 months versus 1.9 months for the placebo group), although tumor regressions were observed only infrequently. Although the target for everolimus, [the serine-th …
Everolimus significantly increased progression-free survival (median PFS for the everolimus treated group was 4.0 months versus 1.9 months f …
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A, Schwartz S, Vinks AA, Heldrup J. Ramsey LB, et al. Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Oncologist. 2018. PMID: 29079637 Free PMC article.
Acute kidney injury due to high-dose methotrexate (HDMTX) is a serious, life-threatening toxicity that can occur in pediatric and adult patients. Glucarpidase is a treatment approved by the Food and Drug Administration for high methotrexate concentrations in the context of …
Acute kidney injury due to high-dose methotrexate (HDMTX) is a serious, life-threatening toxicity that can occur in pediatric and adu …
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. Trpkov K, et al. Mod Pathol. 2021 Jul;34(7):1392-1424. doi: 10.1038/s41379-021-00779-w. Epub 2021 Mar 4. Mod Pathol. 2021. PMID: 33664427 Free article.
Papillary RCC subtyping is no longer recommended, as WHO/ISUP grade and tumor architecture better predict outcome. New papillary RCC variants/patterns include biphasic, solid, Warthin-like, and papillary renal neoplasm with reverse polarity. For tumors with 'borderl …
Papillary RCC subtyping is no longer recommended, as WHO/ISUP grade and tumor architecture better predict outcome. New papillary RCC …
Wilms tumor genetics.
Huff V. Huff V. Am J Med Genet. 1998 Oct 2;79(4):260-7. doi: 10.1002/(sici)1096-8628(19981002)79:4<260::aid-ajmg6>3.0.co;2-q. Am J Med Genet. 1998. PMID: 9781905 Review.
Wilms tumor (WT), a sporadic and familial childhood kidney tumor, is genetically heterogeneous. One WT gene, WT1 at 11p13, has been cloned, but only a minority of WTs carry detectable mutations at that locus. ...In addition to WT1 and the familial predisposition gen …
Wilms tumor (WT), a sporadic and familial childhood kidney tumor, is genetically heterogeneous. One WT gene, WT1 at 11p13, has …
Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer.
Wu NL, Chen Y, Dieffenbach BV, Ehrhardt MJ, Hingorani S, Howell RM, Jefferies JL, Mulrooney DA, Oeffinger KC, Robison LL, Weil BR, Yuan Y, Yasui Y, Hudson MM, Leisenring WM, Armstrong GT, Chow EJ. Wu NL, et al. J Clin Oncol. 2023 Apr 20;41(12):2258-2268. doi: 10.1200/JCO.22.01926. Epub 2023 Feb 16. J Clin Oncol. 2023. PMID: 36795981 Free PMC article.
PURPOSE: Kidney failure is a rare but serious late effect following treatment for childhood cancer. We developed a model using demographic and treatment characteristics to predict individual risk of kidney failure among 5-year survivors of childhood …
PURPOSE: Kidney failure is a rare but serious late effect following treatment for childhood cancer. We developed a model using …
Pesticides and childhood cancer.
Zahm SH, Ward MH. Zahm SH, et al. Environ Health Perspect. 1998 Jun;106 Suppl 3(Suppl 3):893-908. doi: 10.1289/ehp.98106893. Environ Health Perspect. 1998. PMID: 9646054 Free PMC article. Review.
Although these studies have been limited by nonspecific pesticide exposure information, small numbers of exposed subjects, and the potential for case-response bias, it is noteworthy that many of the reported increased risks are of greater magnitude than those observed in s …
Although these studies have been limited by nonspecific pesticide exposure information, small numbers of exposed subjects, and the potential …
Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib.
Yang D, Chen F, Gong D, Zeng L, Xiang D, He Y, Chen L, Yan J, Zhang S. Yang D, et al. Pediatr Surg Int. 2022 Mar;38(3):465-472. doi: 10.1007/s00383-021-05043-5. Epub 2022 Jan 15. Pediatr Surg Int. 2022. PMID: 35032209
BACKGROUND: Hepatoblastoma (HB) is a common primary malignant liver tumour in children, mainly treated by means of traditional chemotherapy using platinum and doxorubicin (ADM). ...There was no obvious damage of the drugs to the heart, liver and kidney of the mice, …
BACKGROUND: Hepatoblastoma (HB) is a common primary malignant liver tumour in children, mainly treated by means of traditional chemot …
Evaluation of kidney dysfunction in childhood cancer survivors.
Mahmoud AAS, Elsalam HBA, El-Deeb SM, Zanaty FM, Aboelghar HM, Elharoun MS. Mahmoud AAS, et al. Pediatr Res. 2022 Dec;92(6):1689-1694. doi: 10.1038/s41390-022-02015-w. Pediatr Res. 2022. PMID: 35338352 Free PMC article.
IMPACT: Detection of kidney dysfunction mainly tubular in childhood cancer survivors after finishing chemotherapy. Urinary NGAL is a good predictor for detection of tubular dysfunction in childhood cancer survivors after finishing chemotherapy....
IMPACT: Detection of kidney dysfunction mainly tubular in childhood cancer survivors after finishing chemotherapy. Urinary NGA …
Origins of DNA methylation defects in Wilms tumors.
Anvar Z, Acurzio B, Roma J, Cerrato F, Verde G. Anvar Z, et al. Cancer Lett. 2019 Aug 10;457:119-128. doi: 10.1016/j.canlet.2019.05.013. Epub 2019 May 16. Cancer Lett. 2019. PMID: 31103718 Review.
Alterations in DNA methylation, in contrast, are frequent molecular defects observed in most cases of Wilms tumors. How these epimutations are established in this tumor is not yet completely clear. ...Here, we provide an overview of the DNA methylation alterations obser …
Alterations in DNA methylation, in contrast, are frequent molecular defects observed in most cases of Wilms tumors. How these epimuta …
294 results